Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HNRNPA1P62, or Heterogeneous nuclear ribonucleoprotein A1 pseudogene 62, is a pseudogene—meaning it is a non-functional copy of the active HNRNPA1 gene that encodes the hnRNP A1 protein[1]. Pseudogenes are DNA sequences derived from ancestral or active genes but usually accumulate mutations that prevent them from producing a functional protein[7]. While some pseudogenes have regulatory, epigenetic, or non-coding RNA roles in certain biological contexts (e.g., as competitive endogenous RNAs in cancer), there is no specific evidence that HNRNPA1P62 has direct biological or pathological significance. Unlike the parent HNRNPA1 gene/protein, HNRNPA1P62 does not participate in RNA binding, RNA splicing, or regulation of gene expression, nor is it a recognized drug target or biomarker[1][7]. If the intent is to study therapeutic targets in the hnRNP family, the protein-coding gene **HNRNPA1** (heterogeneous nuclear ribonucleoprotein A1) would be the canonical molecule of interest, distinct from this pseudogene.
None currently described—for drugs, since it is not a functional protein target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 62 (HNRNPA1P62).